Shares of Phreesia, Inc. (PHR) plummeted 5.25% in Wednesday's intraday trading, despite the company reporting better-than-expected fiscal first-quarter results. The healthcare software firm posted a narrower net loss and higher revenue compared to the same period last year, but investors seemed unimpressed.
For the quarter ended April 30, Phreesia reported a net loss of $0.07 per diluted share, significantly improving from a $0.35 loss in the previous year and beating analysts' expectations of a $0.12 loss. Revenue for the quarter rose to $115.9 million from $101.2 million a year earlier, surpassing the FactSet consensus estimate of $114.9 million.
Despite the positive results, the stock's sharp decline suggests that investors may have been looking for even stronger performance or guidance. Phreesia reiterated its fiscal 2026 revenue guidance of $472 million to $482 million, which aligns with analysts' expectations of $475.5 million. The company also provided an outlook for fiscal year adjusted EBITDA of $85-90 million. The market's reaction indicates that these projections may not have met the high expectations set by some investors, leading to the sell-off despite the company's improved financial performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.